1. Nikolai Khaltaev GARD Meeting ERS Congress 3 September, Munich
Mid Term Financial Report
January – July 2006
Nikolai Khaltaev GARD Meeting ERS Congress 3 September, Munich

2. Overview GARD Contributions

3. Companies accepted by WHO as GARD Observers
Altana Pharma
Astra Zeneca
Boehringer-Ingelheim Int. GmbH
Chiesi Farmaceutici S.p.A.
GlaxoSmithKline
Merck & Co., Inc.
Mitsubishi Pharma Corporation
Novartis Pharma AG
Pfizer Inc.
Sanofi-Aventis
Schering Plough Corporation
Stallergens SA
UCB Farchim SA

4. Overview GARD Expenses

5. Detailed GARD Expenses obligated from GARD Participants

6. Detailed GARD Expenses obligated from GARD Observers

7. Remaining Balance Total Allotted Contributions 465,651
Total Obligated and Earmarked Expenses
419,016
Remaining Balance
46,635